Yifang Han
- Epidemiology top 10%
- Hepatology top 2%
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Co-authors
- Guangwen CaoJianhua YinHongyang WangYan DuHongwei ZhangYang DengJie XueNan Li
- Topics
- Liver Disease Diagnosis and Treatment (6 papers)Hepatitis B Virus Studies (5 papers)MicroRNA in disease regulation (4 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Yifang Han
22 papers receiving 781 citations
Peers
Comparison fields: 5 of 67
- Epidemiology 350
- Hepatology 300
- Molecular Biology 269
- Cancer Research 192
- Oncology 141
Countries citing papers authored by Yifang Han
This map shows the geographic impact of Yifang Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifang Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifang Han more than expected).
Fields of papers citing papers by Yifang Han
This network shows the impact of papers produced by Yifang Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifang Han. The network helps show where Yifang Han may publish in the future.
Co-authorship network of co-authors of Yifang Han
This figure shows the co-authorship network connecting the top 25 collaborators of Yifang Han. A scholar is included among the top collaborators of Yifang Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifang Han. Yifang Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | 51 | |
| 6 | 9 | |
| 7 | 13 | |
| 8 | 61 | |
| 9 | 30 | |
| 10 | 52 | |
| 11 | 60 | |
| 12 | [Association of epithermal growth factor receptor expression and its downstream gene mutation status with radiosensitivity of colorectal carcinoma cell lines in vitro]. | 1 |
| 13 | 28 | |
| 14 | 60 | |
| 15 | 17 | |
| 16 | [Down regulation of multidrug resistance-associated protein 4 expression by RNA interference enhances radiosensitivity of colorectal carcinoma cell lines in vitro]. | 2 |
| 17 | 30 | |
| 18 | 1 | |
| 19 | 44 | |
| 20 | 52 |
About Yifang Han
Yifang Han is a scholar working on Hepatology, Cancer Research and Endocrinology, having authored 27 papers that have together received 793 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis B Virus Studies (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Hepatology (300 citations), Cancer Research (192 citations) and Epidemiology (350 citations). Yifang Han has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Guangwen Cao, Jianhua Yin, Hongyang Wang, Yan Du, Hongwei Zhang, Yang Deng, Jie Xue, Hongwei Zhang, Nan Li and Wei‐Xing Guo. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.